Rare diseases
Investigational molecules
Locations
Back to Portugal498 clinical trials in Porto, Portugal across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors
PortugalStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PortugalStudy on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria
PortugalStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
PortugalStudy on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors
PortugalStudy on the Safety and Effectiveness of Cibotercept (KER-012) with Other Drugs for Adults with Pulmonary Arterial Hypertension
PortugalStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PortugalStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
PortugalStudy on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
PortugalStudy of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
PortugalStudy on Elinzanetant for Treating Hot Flashes in Women with or at High Risk for Hormone-Receptor Positive Breast Cancer
PortugalStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on polypoidal choroidal vasculopathy and rare genetic conditions like PMM2-CDG, exploring new treatment approaches to improve patient outcomes.
Groundbreaking studies in chronic myelogenous leukemia, multiple myeloma, and advanced malignancies, including research on novel therapies for non-small cell lung cancer.
Comprehensive research into conditions like hidradenitis suppurativa, plaque psoriasis, and pyoderma gangrenosum, evaluating new therapeutic approaches.
Studies examining hypertrophic cardiomyopathy, familial hypercholesterolemia, and innovative treatments for obesity.
Investigating treatments for Dravet Syndrome, menstrual migraine, and rare conditions like Niemann-Pick disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
